Published: July 23, 2025
Early recognition of Parkinson’s disease requires health care providers to look beyond the classic tremor. Parkinson’s disease affects approximately 1 million people in the United States, with 90,000 new diagnoses each year. Despite its prevalence, early recognition remains challenging for health care providers.Parkinson’s disease is the most common neurodegenerative movement disorder, characterized by abnormal movement patterns, including difficulty moving, slowness, stiffness and tremor.“Everybody thinks about tremor, and certainly many with Parkinson’s have tremor, but about 20% of patients with Parkinson’s don’t have tremor,” said Jason L. Crowell, M.D., neurologist and movement disorder specialist at Norton Neuroscience Institute. “It is not uncommon for there to be a delay in diagnosis in patients who present without a tremor.”
Health care providers should maintain a high index of suspicion for certain motor and nonmotor symptoms:
The classic triad includes:
These symptoms typically present asymmetrically, affecting one side of the body more than the other, initially.
Several nonmotor symptoms may precede motor manifestations:
When evaluating patients, health care providers should inquire about the specific functional changes that families might observe:
Changes in movement and gait
Fine motor skills
Sleep and sensory changes
Providers should use the following clinical evaluation approach when Parkinson’s disease is suspected:
Consider increased surveillance in patients with the following risk factors:
Primary care providers should consider referral to a movement disorders specialist when:
The Norton Neuroscience Institute Cressman Parkinson’s & Movement Disorders Center is dedicated to offering the most advanced treatments and support for people with Parkinson’s disease. To detect early signs of Parkinson’s, health care providers must look for symptoms beyond the classic tremor and focus on the constellation of motor and nonmotor symptoms, particularly bradykinesia and rigidity.In maintaining clinical suspicion, providers should ask targeted questions about functional changes, recognizing that early symptoms, though seemingly unrelated, may form a cohesive clinical picture. The goal of early recognition extends beyond diagnosis; it enables timely interventions that can preserve quality of life and potentially slow disease progression. Norton Neuroscience Institute offers some of the most advanced treatments available to help control symptoms.